Lipocine Inc.

LPCN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Feb 18, 2021 FORM 8-K
SC 13G/A Feb 11, 2021
SC 13G/A Feb 10, 2021 LPCN 13GA
SC 13G Feb 10, 2021 SCHEDULE 13G
8-K Jan 28, 2021 FORM 8-K
8-K Jan 27, 2021 FORM 8-K
424B5 Jan 27, 2021 424B5
8-K Jan 25, 2021 FORM 8-K
424B5 Jan 25, 2021 424B5
8-K Jan 14, 2021 8-K
8-K Jan 12, 2021 FORM 8-K
SC 13G/A Jan 5, 2021 SABBY 13G-A LPCN 1.05.21
4 Jan 4, 2021 PRIMARY DOCUMENT
4 Jan 4, 2021 PRIMARY DOCUMENT
8-K Jan 4, 2021 FORM 8-K
8-K Dec 30, 2020 FORM 8-K
4 Dec 29, 2020 PRIMARY DOCUMENT
8-K Dec 29, 2020 FORM 8-K
4 Dec 17, 2020 PRIMARY DOCUMENT
4 Dec 17, 2020 PRIMARY DOCUMENT
4 Dec 17, 2020 PRIMARY DOCUMENT
4 Dec 17, 2020 PRIMARY DOCUMENT
4 Dec 17, 2020 PRIMARY DOCUMENT
4 Dec 17, 2020 PRIMARY DOCUMENT
8-K Dec 9, 2020 8-K
← Newer Page 13 of 33 · 821 filings Older →